RT Journal Article SR Electronic T1 ClinGen Variant Curation Interface: A Variant Classification Platform for the Application of Evidence Criteria from ACMG/AMP Guidelines JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.02.12.21251663 DO 10.1101/2021.02.12.21251663 A1 Christine G. Preston A1 Matt W. Wright A1 Rao Madhavrao A1 Steven M. Harrison A1 Jennifer L. Goldstein A1 Xi Luo A1 Hannah Wand A1 Bryan Wulf A1 Gloria Cheung A1 Mark E. Mandell A1 Howard Tong A1 Shaung Cheng A1 Michael A. Iacocca A1 Arturo Lopez Pineda A1 Alice B. Popejoy A1 Karen Dalton A1 Jimmy Zhen A1 Selina S. Dwight A1 Lawrence Babb A1 Marina DiStefano A1 Julianne M. O’Daniel A1 Kristy Lee A1 Erin R. Riggs A1 Diane B. Zastrow A1 Jessica L. Mester A1 Deborah I. Ritter A1 Ronak Y. Patel A1 Sai Lakshmi Subramanian A1 Aleks Milosavljevic A1 Jonathan S. Berg A1 Heidi L. Rehm A1 Sharon E. Plon A1 J. Michael Cherry A1 Carlos D. Bustamante A1 Helio A. Costa A1 on behalf of the Clinical Genome (ClinGen) Resource YR 2021 UL http://medrxiv.org/content/early/2021/02/18/2021.02.12.21251663.abstract AB Background Identification of clinically significant genetic alterations involved in human disease has been dramatically accelerated by developments in next-generation sequencing technologies. However, the infrastructure and accessible comprehensive curation tools necessary for analyzing an individual patient genome and interpreting genetic variants to inform healthcare management have been lacking.Results Here we present the ClinGen Variant Curation Interface (VCI), a global open-source variant classification platform for supporting the application of evidence criteria and classification of variants based on the ACMG/AMP variant classification guidelines. The VCI is among a suite of tools developed by the NIH-funded Clinical Genome Resource (ClinGen) Consortium, and supports an FDA-recognized human variant curation process. Essential to this is the ability to enable collaboration and peer review across ClinGen Expert Panels supporting users in comprehensively identifying, annotating, and sharing relevant evidence while making variant pathogenicity assertions. To facilitate evidence-based improvements in human variant classification, the VCI is publicly available to the genomics community and is available at https://curation.clinicalgenome.org. Navigation workflows support users providing guidance to comprehensively apply the ACMG/AMP evidence criteria and document provenance for asserting variant classifications.Conclusion The VCI offers a central platform for clinical variant classification that fills a gap in the learning healthcare system, and facilitates widespread adoption of standards for clinical curation.Competing Interest StatementDisclosure: S.E.P. is a member of the Baylor Genetics Scientific Advisory Panel. A.M. is an employee of Baylor College of Medicine (BCM) and performs integration consulting services for BCM-developed software including Genboree through IP Genesis Inc. C.D.B. is on the scientific advisory boards (SAB) of AncestryDNA, Arc Bio LLC, Etalon DX, Liberty Biosecurity, and Personalis. C.D.B. is on the board of EdenRoc Sciences LLC. C.D.B. is also a founder and SAB chair of ARCBio. J.L.M. is an employee of GeneDx/BioReference Laboratories, Inc./OPKO Health and has a salary as the only disclosure. None of these entities played a role in the design, execution, interpretation, or presentation of this study.Funding StatementSources of support: This research was funded by grants from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (U41HG009649, U01HG007436, U41HG006834, U01HG007434, U41HG009650).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB approval not necessaryAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code for the VCI including front-end, back-end, database schemas, analysis pipelines, and user interfaces are freely available under MIT Open Source licenses via the GitHub repositories (https://github.com/ClinGen/ and https://github.com/ClinGen/clincoded/).https://github.com/ClinGen/https://github.com/ClinGen/clincoded/